Philip Taylor | Investor Relations |
Drew Spaventa | Founder & Chief Executive Officer |
Dalen Meeter | Head of Finance |
Dave Daly | President & Chief Operating Officer |
Eli Glezer | Founder & Chief Scientific Officer |
Michael Ryskin | Bank of America |
Tom Stevens | Cowen |
John Sourbeer | UBS |
Greetings and welcome to the Singular Genomics Third Quarter Results and Business Update Call. At this time, all participants are in a listen-only mode, and this call is being recorded. It is my pleasure to introduce your host, Philip Taylor, from Investor Relations.
You may begin.
Thank you, operator.